34 results
Page 2 of 2
8-K
EX-99.1
358m7x13nrej vwqp
26 May 22
Candel Therapeutics Announces Release of Initial Data on CAN-2409 in a Phase 2 Clinical Trial Showing Cytotoxic T Cell Response and Disease Control in Patients with Non-Small Cell Lung Cancer
5:36pm
10-K
59287ljhojuvp 7sg
29 Mar 22
Annual report
8:46am
10-Q
vgk3u lrqk
8 Sep 21
Quarterly report
8:37am
424B4
h0pa64yua jjo
28 Jul 21
Prospectus supplement with pricing info
4:02pm
S-1/A
7wpf81kugme14 zjux2g
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.10
etebdrtndum3r pl2
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-1.1
7oos shh5padxk9
16 Jul 21
IPO registration (amended)
6:07am
S-1
6snf4x
25 Jun 21
IPO registration
5:28pm
S-1
EX-10.10
ytkniah2
25 Jun 21
IPO registration
5:28pm
DRS/A
za81 ft3izd0tjz6ehj
31 Mar 21
Draft registration statement (amended)
12:00am